Development and validation of an integrated machine learning model for recurrence-free survival prediction in clear cell renal cell carcinoma
Model outperforms UISS/SSIGN, enabling precise ccRCC risk stratification and clinical decision support, and achieves excellent external C-index with robust multi-year RFS prediction.